| # |
Company Name
|
Industry Name
|
Latest Price (Rs.)
|
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Pharma | Pharmaceuticals& Drugs | 764.9 |
10.4 (1.38%) |
Small Cap | 6,672 | 32 | 8.29 | 23.9 | 2.8 | |
| Piramal Pharma | Pharmaceuticals& Drugs | 160.3 |
-1.6 (-0.99%) |
Small Cap | 5,286 | 5.3 | 13.11 | 30.4 | 2.6 | |
| Ajanta Pharma | Pharmaceuticals& Drugs | 2,904.2 |
79.55 (2.82%) |
Small Cap | 4,648 | 81.2 | 19.35 | 35.8 | 7.9 | |
| Natco Pharma | Pharmaceuticals& Drugs | 1,113.6 |
17.75 (1.62%) |
Small Cap | 4,430 | 86.9 | 40.5 | 12.8 | 2.3 | |
| Emcure Pharma | Pharmaceuticals& Drugs | 1,785.2 |
105.2 (6.26%) |
Small Cap | 4,382 | 33.7 | 6.24 | 53 | 9.8 | |
| Aster DM Healthcare | Hospital &HealthcareServices | 744.7 |
43.3 (6.17%) |
Small Cap | 4,138 | 7.5 | 8.01 | 99.4 | 8.4 | |
| Gland Pharma | Pharmaceuticals& Drugs | 1,817.3 |
66.3 (3.79%) |
Small Cap | 4,116 | 71 | 26.26 | 25.6 | 2.9 | |
| JB Chem & Pharma | Pharmaceuticals& Drugs | 2,078.6 |
30.45 (1.49%) |
Small Cap | 3,723 | 45.3 | 16.97 | 45.9 | 8.6 | |
| Global Health | Hospital &HealthcareServices | 1,171 |
53.35 (4.77%) |
Small Cap | 3,204 | 17.3 | 15.48 | 67.6 | 8.1 | |
| Granules India | Pharmaceuticals& Drugs | 703.6 |
4.3 (0.61%) |
Small Cap | 3,030 | 16.2 | 9.87 | 43.5 | 4 | |
| Wockhardt | Pharmaceuticals& Drugs | 1,425.5 |
30.9 (2.22%) |
Small Cap | 3,012 | 13.1 | -1.8 | 108.8 | 5 | |
| Eris Lifesciences | Pharmaceuticals& Drugs | 1,354.1 |
31.3 (2.37%) |
Small Cap | 2,894 | 31.2 | 12.9 | 43.5 | 5.2 | |
| Dishman Carbogen Amc | Pharmaceuticals& Drugs | 186.7 |
3.1 (1.69%) |
Small Cap | 2,712 | 7.6 | 0.85 | 24.6 | 0.5 | |
| Aarti Drugs | Pharmaceuticals& Drugs | 394.9 |
19.85 (5.29%) |
Small Cap | 2,387 | 22.2 | 7.04 | 17.8 | 2.4 | |
| Alivus Life Sciences | Pharmaceuticals& Drugs | 1,067.9 |
30.35 (2.93%) |
Small Cap | 2,387 | 44.3 | 20.07 | 24.1 | 4.1 | |
| Dr. Lal Pathlabs | Hospital &HealthcareServices | 1,573.5 |
205.35 (15.01%) |
Small Cap | 2,352 | 30.3 | 21.21 | 51.9 | 10.7 | |
| Pfizer | Pharmaceuticals& Drugs | 4,683.7 |
-24.45 (-0.52%) |
Small Cap | 2,281 | 186.6 | 28.39 | 25.1 | 5.4 | |
| Strides Pharma Scien | Pharmaceuticals& Drugs | 1,031.5 |
-4.9 (-0.47%) |
Small Cap | 2,139 | 19.9 | 2.46 | 51.8 | 2.9 | |
| IOL Chem & Pharma | Pharmaceuticals& Drugs | 94.9 |
0.74 (0.79%) |
Small Cap | 2,079 | 4 | 4.59 | 24 | 1.6 | |
| FDC | Pharmaceuticals& Drugs | 372 |
7.3 (2%) |
Small Cap | 2,070 | 14 | 12.16 | 26.7 | 2.5 | |
| Caplin Point Lab | Pharmaceuticals& Drugs | 1,735.9 |
25.3 (1.48%) |
Small Cap | 1,937 | 80.7 | 27.17 | 21.5 | 4 | |
| Hikal | Pharmaceuticals& Drugs | 194.7 |
4.8 (2.53%) |
Small Cap | 1,860 | -1.1 | 4.72 | - | 2 | |
| Sanofi India | Pharmaceuticals& Drugs | 3,400.4 |
-7.55 (-0.22%) |
Small Cap | 1,837 | 134.5 | 18.75 | 25.3 | 10 | |
| Aarti Pharmalabs | Pharmaceuticals& Drugs | 805.7 |
61.45 (8.26%) |
Small Cap | 1,771 | 23.7 | 14.41 | 34 | 3.8 | |
| Unichem Lab | Pharmaceuticals& Drugs | 385.6 |
-3.75 (-0.96%) |
Small Cap | 1,736 | 32 | 8.09 | 12 | 1 |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: